Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Calgary
$105,000.00
The role of natriuretic peptide receptors in regulating electrical conduction and structural remodeling of the sinoatrial node in a mouse model of hypertensive heart disease.
FY 2018-19
Summary
Cardiovascular diseases are the leading cause of death globally. They are often associated with the generation of arrhythmias (abnormal patterns in the heart beat), including sinoatrial node arrhythmias and atrial fibrillation, that increase morbidity and mortality. The basis for sinoatrial node disease and atrial fibrillation in heart disease is very poorly understood. Accordingly, there is a clear need for experimental work that will improve our understanding of these conditions and that will lead to the development new therapeutic approaches. In the Rose lab, we are studying how a family of protective hormones, called natriuretic peptides, can be used to treat or prevent sinoatrial node dysfunction and atrial fibrillation in heart disease. Our new and exciting work in this area suggests that natriuretic peptides may play a significant role in limiting the progression of heart disease. We propose a study that will investigate the mechanisms by which these hormones function to protect the heart against adverse arrhythmias in heart disease. This study will generate critical new insight into how different targets that are affected by natriuretic peptides affect in the occurrence of arrhythmias. The goal of our work is to generate new synthetic natriuretic peptides that can be used to treat patients with heart disease.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
404106
Name
Mackasey Martin
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The role of natriuretic peptide receptors in regulating electrical conduction and structural remodeling of the sinoatrial node in a mouse model of hypertensive heart disease.
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Atrial Fibrillation; Cardiac Fibrosis; Cardiovascular Disease; Electrophysiology; Gene Expression; Heart Failure; Histology; Natriuretic Peptides; Optical Mapping; Sinoatrial Node Disease
Abstract
Cardiovascular diseases are the leading cause of death globally. They are often associated with the generation of arrhythmias (abnormal patterns in the heart beat), including sinoatrial node arrhythmias and atrial fibrillation, that increase morbidity and mortality. The basis for sinoatrial node disease and atrial fibrillation in heart disease is very poorly understood. Accordingly, there is a clear need for experimental work that will improve our understanding of these conditions and that will lead to the development new therapeutic approaches. In the Rose lab, we are studying how a family of protective hormones, called natriuretic peptides, can be used to treat or prevent sinoatrial node dysfunction and atrial fibrillation in heart disease. Our new and exciting work in this area suggests that natriuretic peptides may play a significant role in limiting the progression of heart disease. We propose a study that will investigate the mechanisms by which these hormones function to protect the heart against adverse arrhythmias in heart disease. This study will generate critical new insight into how different targets that are affected by natriuretic peptides affect in the occurrence of arrhythmias. The goal of our work is to generate new synthetic natriuretic peptides that can be used to treat patients with heart disease.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mackasey, Martin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~